focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Regulatory News (ZTF)

Share Price Information for Zotefoams (ZTF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 514.00
Bid: 518.00
Ask: 526.00
Change: 26.00 (5.33%)
Spread: 8.00 (1.544%)
Open: 488.00
High: 540.00
Low: 488.00
Prev. Close: 488.00
ZTF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Finance Director Designate

24 Nov 2015 07:00

RNS Number : 6344G
Zotefoams PLC
24 November 2015
 



24 November 2015

 

Zotefoams plc

("Zotefoams" or "the Company")

 

Appointment of Finance Director Designate

 

 

Zotefoams plc, a world leader in cellular material technology, is pleased to announce the appointment of Gary McGrath to its Board as Finance Director Designate, effective 1 December 2015. As announced in May 2015, Clifford Hurst, our Finance Director for the last 15 years, indicated his intention to retire during 2016 and this appointment will allow a well-managed transition of responsibilities through our budgeting process and financial year-end.

 

Initially, Gary will be appointed to the Board and will work closely with Clifford to achieve a formal handover of the role of Finance Director during the first quarter of 2016. Clifford will retire from the Board and the Company in advance of the AGM in May 2016.

 

Gary qualified as a Chartered Accountant with Arthur Andersen and spent 11 years at RMC Group plc before joining Koch Industries Inc., where he spent seven years in various positions, including Global Finance Director of INVISTA Apparel and EMEA Vice President Finance, Planning & Analysis at Georgia Pacific, both Koch subsidiary companies. Most recently, Gary was Chief Financial Officer of G C Aesthetics Limited. Gary has worked across public, private and private equity environments in the UK, Belgium, Germany, the USA and the Republic of Ireland.

 

David Stirling, Group CEO of Zotefoams, comments: "On behalf of the Board, we are delighted that Gary will be joining the Company. His considerable financial and international experience will be of great benefit to Zotefoams as we continue to develop our global presence and we look forward to working with him.

 

"We would also like to thank Clifford for his invaluable contribution to the Company during his tenure. Clifford has supported Zotefoams through a period of significant growth, development and investment and we wish him well in his retirement."

 

Neither Gary McGrath nor his connected persons currently hold any shares in Zotefoams plc.

 

The Company confirms that there are no further details required to be disclosed under paragraph LR 9.6.13 R of the UK Listing Rules in respect of Mr McGrath.

 

 

 

Enquiries:

Zotefoams plc

Tel: 0208-664-1600

David Stirling, Group CEO

Clifford Hurst, Finance Director

FTI Consulting

Tel: 0203-727-1000

Victoria Foster Mitchell / Simon Conway

 

 

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular material technology. Using a unique manufacturing process with environmentally friendly nitrogen expansion, Zotefoams produces lightweight foams in Croydon, UK and Kentucky, USA for diverse markets worldwide through its global sales force. Zotefoams also owns and licenses patented MuCell® microcellular foam technology from a base in Massachusetts, USA to customers worldwide and sells T-Tubes® advanced insulation systems made from its patented ZOTEK® fluoropolymer foams.

 

www.zotefoams.com

 

ZOTEK® is a registered trademark of Zotefoams plc. MuCell® is a registered trademark of Trexel Inc. T-Tubes® is a registered trademark of UFP Technologies Inc.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFEFLSLVFIE
Date   Source Headline
19th Jul 20231:29 pmRNSHolding(s) in Company
18th Jul 20237:00 amRNSJoint development agreement for ReZorce®
12th Jul 202311:01 amRNSNotification Of Transactions Of Directors/PDMRs
10th Jul 20237:00 amRNSNotice of results and investor presentation
22nd Jun 20232:20 pmRNSHolding(s) in Company
20th Jun 202310:16 amRNSNotification Of Transactions Of Directors/PDMRs
14th Jun 20237:00 amRNSHolding(s) in Company
13th Jun 20232:55 pmRNSNOTIFICATION OF TRANSACTIONS OF DIRECTORS/PDMRs
6th Jun 20231:34 pmRNSNotification Of Transactions Of Directors/PDMRs
6th Jun 20238:00 amRNSNike Exclusivity Agreement Extension
24th May 202311:40 amRNSResult of the 2023 Annual General Meeting
24th May 20237:00 amRNSTrading Update and Chair Succession
12th May 202310:42 amRNSNotification Of Transactions Of Directors/PDMRs
27th Apr 20237:00 amRNSHigh-performance foam in medical facility doors
26th Apr 20235:44 pmRNSNotification Of Transactions Of Directors/PDMRs
26th Apr 20233:39 pmRNSNotification Of Transactions Of Directors/PDMRs
24th Apr 20235:50 pmRNSReplacement Notice Transactions Of Directors/PDMRs
24th Apr 20234:42 pmRNSNotification Of Transactions Of Directors/PDMRs
21st Apr 20237:00 amRNS2022 Annual Report and Notice of the 2023 AGM
19th Apr 20234:41 pmRNSNotification Of Transactions Of Directors/PDMRs
12th Apr 20231:18 pmRNSNotification Of Transactions Of Directors/PDMRs
27th Mar 20234:35 pmRNSPrice Monitoring Extension
22nd Mar 20231:30 pmRNSHolding(s) in Company
21st Mar 20234:10 pmRNSNotification Of Transactions Of Directors/PDMRs
21st Mar 20234:09 pmRNSHolding(s) in Company
21st Mar 20237:00 amRNSPreliminary Results
14th Mar 20234:58 pmRNSHolding(s) in Company
14th Mar 20233:09 pmRNSNotification Of Transactions Of Directors/PDMRs
28th Feb 20237:00 amRNSAward of AA ESG Ratings assessment
15th Feb 20237:00 amRNSNotice of Results
14th Feb 20233:34 pmRNSNotification Of Transactions Of Directors/PDMRs
3rd Feb 20234:35 pmRNSPrice Monitoring Extension
19th Jan 20237:00 amRNSFull Year Trading Update
17th Jan 20237:00 amRNSChair Succession
12th Jan 202311:18 amRNSNotification Of Transactions Of Directors/PDMRs
15th Dec 20227:00 amRNSTrading Update
13th Dec 20224:03 pmRNSNotification Of Transactions Of Directors/PDMRs
6th Dec 20229:42 amRNSNotification Of Transactions Of Directors/PDMRs
5th Dec 202211:34 amRNSNotification Of Transactions Of Directors/PDMRs
14th Nov 202211:27 amRNSNotification Of Transactions Of Directors/PDMRs
14th Nov 20227:00 amRNSAppointment of Joint Broker
9th Nov 20227:00 amRNSAcquisition of the assets and IP of Refour ApS
17th Oct 202211:31 amRNSNotification Of Transactions Of Directors/PDMRs
13th Oct 20227:00 amRNSTrading Update
12th Oct 20224:02 pmRNSNotification Of Transactions Of Directors/PDMRs
11th Oct 20224:41 pmRNSSecond Price Monitoring Extn
11th Oct 20224:35 pmRNSPrice Monitoring Extension
27th Sep 20227:00 amRNSIndependent Life Cycle Assessment of ReZorce
13th Sep 20223:43 pmRNSDirector/PDMR Shareholding
23rd Aug 20224:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.